GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » GC Cell Corp (XKRX:144510) » Definitions » ROE % Adjusted to Book Value

GC Cell (XKRX:144510) ROE % Adjusted to Book Value : -5.97% (As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is GC Cell ROE % Adjusted to Book Value?

GC Cell's ROE % for the quarter that ended in Mar. 2024 was -7.16%. GC Cell's PB Ratio for the quarter that ended in Mar. 2024 was 1.20. GC Cell's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 was -5.97%.


GC Cell ROE % Adjusted to Book Value Historical Data

The historical data trend for GC Cell's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GC Cell ROE % Adjusted to Book Value Chart

GC Cell Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.55 0.44 3.77 3.63 -0.02

GC Cell Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.81 -1.53 2.36 1.16 -5.97

Competitive Comparison of GC Cell's ROE % Adjusted to Book Value

For the Diagnostics & Research subindustry, GC Cell's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GC Cell's ROE % Adjusted to Book Value Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, GC Cell's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where GC Cell's ROE % Adjusted to Book Value falls into.



GC Cell ROE % Adjusted to Book Value Calculation

GC Cell's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-0.03% / 1.28
=-0.02%

GC Cell's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-7.16% / 1.20
=-5.97%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


GC Cell ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of GC Cell's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


GC Cell (XKRX:144510) Business Description

Traded in Other Exchanges
N/A
Address
30 beongil to giheung-gu, Gyeonggi, 107 Lee Hyun, Yongin, KOR, 16 924
GC Cell Corp engages in the provision of anti-cancer immunotherapy. The company is developing an anticancer drug, which is in Phase II clinical trials; and stem cell treatment drugs. It also provides cell banking, sample inspection, clinical trial, and bio logistics services.

GC Cell (XKRX:144510) Headlines

No Headlines